Filing Details
- Accession Number:
- 0001161697-22-000548
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-15 17:00:37
- Reporting Period:
- 2022-11-11
- Accepted Time:
- 2022-11-15 17:00:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1278439 | A Donald Denkhaus | 355 Alhambra Circle Suite 801 Coral Gables FL 33134 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-11-11 | 20,000 | $16.59 | 277,666 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. Denkhaus remains a director of the Company.
- Represents a weighted average price for the shares sold. Shares were sold at prices ranging from $16.58 to $16.65 per share.
Billionaire Hedge Funds
